GSK Infanrix hexa & sudden death: a review of the safety update reports submitted to EMA

In their peer reviewed commentary in the Indian Journal of Medical Ethics, Dr. Jacob Puliyel, Head of Pediatrics, St. Stephen’s Hospital and C Sathyamala, Public Health Physician and Epidemiologist, examine sudden infant deaths following vaccination with GlaxoSmithKline’s hexavalent (6 in 1) “Infanrix hexa” . . . Continue reading →

WHO eliminated death as a consequence of pentavalent vaccine; UK seeks to mandate vaccines

FYI Vaccine regulators are bent on eliminating whatever vestiges of protection might still be in existence. The UK Independent reports that the British Medical Association is calling for evidence to be submitted to the UK Government on:  “the potential advantages and disadvantages of childhood . . . Continue reading →